Every drop counts

Hoxworth rewarding blood donors with special gifts this March

Every drop counts, and Hoxworth Blood Center, University of Cincinnati, is in critical need of blood and platelet donors.

As of February 28, 2023, Hoxworth is in especially critical need of Type O blood donors. All eligible individuals are asked to schedule a donation immediately to help local patients in need.

“Increased usage at area hospitals has depleted our inventory of Type O blood products,” explains Jackie Marschall, spokesperson for Hoxworth Blood Center. “We need the Cincinnati community to schedule a donation as soon as they are able to bolster our blood supply for local patients in need.”

Hoxworth will be thanking donors all month long with special gifts:

  • March 1-2: $20 eGift card for Type O negative donors only at Neighborhood Donor Centers
  • March 1–2: eGift cards for all donors at Neighborhood Donor Centers ($10 whole blood, $15 red cells, $20 platelets) 
  • March 3-24: Free ‘Every Drop Counts’ stainless-steel tumbler for all donors at Neighborhood Donor Centers and select mobile drives.
  • March 27-29: Reds pack jackets at Neighborhood Donor Centers
  • March 30-31: April Fool’s mixed swag at Neighborhood Donor Centers

Appointments are available this week at any of Hoxworth’s seven Neighborhood Donor Centers and mobile blood drives. To schedule a donation, call Hoxworth at 513-451-0910 or visit hoxworth.org

About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.